BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12412180)

  • 1. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
    Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
    Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
    Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
    Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE
    Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma.
    Rumi MA; Sato H; Ishihara S; Kawashima K; Hamamoto S; Kazumori H; Okuyama T; Fukuda R; Nagasue N; Kinoshita Y
    Br J Cancer; 2001 Jun; 84(12):1640-7. PubMed ID: 11401318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.
    Sato H; Ishihara S; Kawashima K; Moriyama N; Suetsugu H; Kazumori H; Okuyama T; Rumi MA; Fukuda R; Nagasue N; Kinoshita Y
    Br J Cancer; 2000 Nov; 83(10):1394-400. PubMed ID: 11044367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.